David P Richman, MD

Professor

UC Davis, Neurology

Emaildprichman@ucdavis.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where David P Richman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Not started
5 Finished

Antigen-specific treatment of myasthenia gravis: Chimeric autoantibody receptor T cells targeting autoimmune B cells
Richman, D. P.
Project: Research project
Development of Animal Models of Anti-MuSK Myasthenia
Richman, D. P.
National Institutes of Health
9/30/10 → 8/31/13
Project: Research project
IX INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS
Richman, D. P.
National Institutes of Health
5/1/97 → 4/30/98
Project: Research project
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
Fairclough, R. H., Richman, D. P., Nelson, D., Martinez-Carrion, M. & Kezdy, F.
National Institutes of Health
1/1/87 → 9/30/92
Project: Research project
PATHOGENIC MECHANISMS IN MYASTHENIA
Richman, D. P.
National Institutes of Health
7/1/84 → 6/30/97
Project: Research project

3810 Citations
31 h-Index
115 Article
4 Review article
3 Letter
2 Chapter
More
- 2 Editorial

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Narayanaswami, P., Sanders, D. B., Wolfe, G., Benatar, M., Cea, G., Evoli, A., Gilhus, N. E., Illa, I., Kuntz, N. L., Massey, J., Melms, A., Murai, H., Nicolle, M., Palace, J., Richman, D. & Verschuuren, J., Jan 19 2021, In: Neurology. 96, 3, p. 114-122 9 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
5 Scopus citations
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America
Green, J. D., Barohn, R. J., Bartoccion, E., Benatar, M., Blackmore, D., Chaudhry, V., Chopra, M., Corse, A., DImachkie, M. M., Evoli, A., Florence, J., Freimer, M., Howard, J. F., Jiwa, T., Kaminski, H. J., Kissel, J. T., Koopman, W. J., Lipscomb, B., Maestri, M., Marino, M. & 20 others, Massey, J. M., McVey, A., Mezei, M. M., Muppidi, S., Nicolle, M. W., Oger, J., Pascuzzi, R. M., Pasnoor, M., Pestronk, A., Provenzano, C., Ricciardi, R., Richman, D. P., Rowin, J., Sanders, D. B., Siddiqi, Z., Soloway, A., Wolfe, G. I., Wulf, C., Drachman, D. B. & Traynor, B. J., Sep 18 2020, In: BMJ open. 10, 9, e037909.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Muscle-Specific Kinase Myasthenia Gravis
Borges, L. S. & Richman, D. P., May 8 2020, In: Frontiers in immunology. 11, 707.
Research output: Contribution to journal › Review article › peer-review

Open Access
2 Scopus citations
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma
Lara, M. S., Afify, A. M., Ellis, M. P., Phan, C., Richman, D. P. & Riess, J., Jan 1 2019, In: Clinical lung cancer.
Research output: Contribution to journal › Article › peer-review

3 Scopus citations
Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia
on behalf of the DAPPER Study Team, Jan 1 2019, In: Muscle and Nerve. 60, 3, p. 292-298 7 p.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations